Insider Transactions in Q4 2025 at Bei Gene, Ltd. (BGNE)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2025
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
24,369
-38.65%
|
$7,359,438
$302.92 P/Share
|
|
Dec 15
2025
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
75,631
-9.04%
|
$23,218,717
$307.94 P/Share
|
|
Dec 11
2025
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
332
-100.0%
|
$107,900
$325.0 P/Share
|
|
Dec 11
2025
|
Chan Henry Lee SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
332
+36.34%
|
$62,416
$188.94 P/Share
|
|
Dec 10
2025
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
332
-100.0%
|
$105,576
$318.28 P/Share
|
|
Dec 10
2025
|
Chan Henry Lee SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
332
+36.34%
|
$62,416
$188.94 P/Share
|
|
Nov 26
2025
|
Corazon (Corsee) D. Sanders Director |
SELL
Open market or private sale
|
Direct |
2,627
-84.7%
|
$895,807
$341.34 P/Share
|
|
Nov 26
2025
|
Corazon (Corsee) D. Sanders Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,627
+50.0%
|
$417,693
$159.03 P/Share
|
|
Nov 17
2025
|
Xiaobin Wu President and COO |
SELL
Open market or private sale
|
Direct |
3,991
-92.62%
|
$1,520,571
$381.25 P/Share
|
|
Nov 13
2025
|
Xiaobin Wu President and COO |
SELL
Open market or private sale
|
Direct |
6,009
-85.28%
|
$2,283,420
$380.69 P/Share
|
|
Nov 12
2025
|
Xiaobin Wu President and COO |
SELL
Open market or private sale
|
Direct |
10,000
-10.14%
|
$3,550,000
$355.43 P/Share
|
|
Nov 12
2025
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
996
-83.33%
|
$347,604
$349.38 P/Share
|
|
Nov 12
2025
|
Chan Henry Lee SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
996
+36.39%
|
$187,248
$188.94 P/Share
|
|
Nov 12
2025
|
John Oyler Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
858,533
-11.76%
|
-
|
|
Nov 11
2025
|
John Oyler Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
151,320
-2.03%
|
-
|
|
Nov 07
2025
|
Xiaodong Wang Director |
SELL
Bona fide gift
|
Direct |
424,073
-8.47%
|
-
|
|
Oct 08
2025
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
10,671
-65.04%
|
$3,724,179
$349.79 P/Share
|
|
Oct 08
2025
|
Chan Henry Lee SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
9,559
+34.06%
|
$1,797,092
$188.94 P/Share
|